A detailed history of Natixis transactions in Viatris Inc stock. As of the latest transaction made, Natixis holds 78,725 shares of VTRS stock, worth $993,509. This represents 0.01% of its overall portfolio holdings.

Number of Shares
78,725
Holding current value
$993,509
% of portfolio
0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$10.32 - $12.13 $812,442 - $954,934
78,725 New
78,725 $913,000
Q1 2024

May 13, 2024

BUY
$11.27 - $13.53 $310,623 - $372,913
27,562 New
27,562 $329,000
Q3 2023

Nov 14, 2023

BUY
$9.59 - $11.35 $74,025 - $87,610
7,719 Added 11.11%
77,166 $760,000
Q2 2023

Aug 11, 2023

BUY
$9.02 - $10.29 $228,602 - $260,789
25,344 Added 57.47%
69,447 $693,000
Q1 2023

May 12, 2023

SELL
$9.2 - $12.26 $1.1 Million - $1.47 Million
-119,862 Reduced 73.1%
44,103 $424,000
Q4 2022

Feb 24, 2023

BUY
$8.72 - $11.56 $202,801 - $268,850
23,257 Added 16.53%
163,965 $1.82 Million
Q4 2022

Feb 13, 2023

SELL
$8.72 - $11.56 $1.91 Million - $2.53 Million
-218,856 Reduced 60.87%
140,708 $1.57 Million
Q3 2022

Nov 14, 2022

BUY
$8.48 - $11.13 $956,781 - $1.26 Million
112,828 Added 45.73%
359,564 $3.07 Million
Q2 2022

Aug 12, 2022

SELL
$9.95 - $12.27 $1.78 Million - $2.2 Million
-179,387 Reduced 42.1%
246,736 $2.58 Million
Q1 2022

May 13, 2022

BUY
$9.81 - $15.4 $1.27 Million - $1.99 Million
129,392 Added 43.61%
426,123 $4.64 Million
Q4 2021

Feb 14, 2022

SELL
$12.09 - $14.68 $4.67 Million - $5.67 Million
-386,397 Reduced 56.56%
296,731 $4.02 Million
Q3 2021

Nov 12, 2021

BUY
$13.25 - $15.13 $9.05 Million - $10.3 Million
683,128 New
683,128 $9.26 Million
Q2 2021

Aug 13, 2021

SELL
$12.97 - $16.15 $1.02 Million - $1.26 Million
-78,292 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$13.59 - $18.54 $12.3 Million - $16.8 Million
-907,430 Reduced 92.06%
78,292 $1.09 Million
Q4 2020

Feb 12, 2021

BUY
$14.3 - $18.74 $14.1 Million - $18.5 Million
985,722 New
985,722 $18.5 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.3B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Natixis Portfolio

Follow Natixis and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.